The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogata, R. T.
Right arrow Articles by Low, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogata, R. T.
Right arrow Articles by Low, P. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

The Journal of Immunology, Vol 155, Issue 5 2642-2651, Copyright © 1995 by American Association of Immunologists

ARTICLES

Complement component C5: engineering of a mutant that is specifically cleaved by the C4-specific C1s protease

RT Ogata and PJ Low
Medical Biology Institute, La Jolla, CA 92037, USA.

Previous studies showed that simply inserting or substituting a few amino acid residues immediately downstream of the proteolytic activation site in C component C3 renders that site susceptible to the C4-specific C1s protease. This report describes the results of extending those studies to the closely related component C5. We found that small changes, similar to those that made C3 susceptible to C1s, were insufficient to render C5 C1s-sensitive; and neither more extensive substitution downstream of the cleavage site with a 14 residue long segment from C4, nor upstream substitution with an 8 residue long C4 segment gave C1s cleavage. However, substitution of both the upstream and downstream segments gave a hybrid C5 protein, designated ASC4, which was cleaved by C1s. The protease sensitivity of ASC4 was curious, however, in that C1s was more active against the secreted extracellular biosynthetic precursor, pro-ASC4(E) than mature ASC4, whereas a C5-specific convertase cleaved the mature protein but not the precursor. In contrast, both mature and precursor forms of wild- type C5 were cleaved by the C5 convertase, but neither of course is recognized by C1s. These results demonstrate that a mutant C5 molecule can be constructed that is cleaved at the activation site by both C1s and C5 convertase. This suggests that the structures necessary for specific recognition by the two proteases have little or no overlap and that recognition by C5 convertase involves residues that are distant from the activation site itself.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
C.-T. Thai and R. T. Ogata
Expression and Characterization of the C345C/NTR Domains of Complement Components C3 and C5
J. Immunol., December 15, 2003; 171(12): 6565 - 6573.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Sandoval, R. Ai, J. M. Ostresh, and R. T. Ogata
Distal Recognition Site for Classical Pathway Convertase Located in the C345C/Netrin Module of Complement Component C5
J. Immunol., July 15, 2000; 165(2): 1066 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. J. Low, R. Ai, and R. T. Ogata
Active Sites in Complement Components C5 and C3 Identified by Proximity to Indels in the C3/4/5 Protein Family
J. Immunol., June 1, 1999; 162(11): 6580 - 6588.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. T. Ogata, R. Ai, and P. J. Low
Active Sites in Complement Component C3 Mapped by Mutations at Indels
J. Immunol., November 1, 1998; 161(9): 4785 - 4794.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.